SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharmaceuticals informs about completion of tenure of independent director

04 Feb 2025 Evaluate

Alembic Pharmaceuticals has informed that, Dr. Archana Hingorani (DIN: 00028037) has completed her second consecutive term of five years as an Independent Director and consequently ceases to be a Director of the Company with effect from end of the day on 3rd February, 2025. The Board of Directors of the Company place on record their sincere appreciation for the contributions made by her during her association with the Company. The details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024 is enclosed as Annexure-I to this letter.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

754.25 -4.75 (-0.63%)
21-Apr-2026 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1671.70
Dr. Reddys Lab 1225.00
Cipla 1233.60
Zydus Lifesciences 932.40
Lupin 2327.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×